In recent years, the number of drug pipelines has steadily increased
Weight Loss Outcomes: What Clinical Evidence Shows Clinical trials have demonstrated that tirzepatide produces greater average weight loss compared to semaglutide in direct comparisons
The metabolic improvements from that degree of weight reduction persist as long as the weight stays off
Common side effects are usually mild to moderate and may include: Nausea Diarrhea Vomiting Stomach pain Redness at the injection site Suppressed appetite Weight loss Low blood sugar (particularly if combined with insulin therapy) Rare but serious side effects can include: Acute pancreatitis, Severe allergic reactions, Impaired kidney function, and Medullary thyroid carcinoma (MTC) Avoid this medication if you have a personal or family history of MTC or multiple endocrine neoplasia, or if you are allergic to dulaglutide
Excess weight places additional stress on joints and muscles, so significant weight loss can decrease pain and strain
receptor pharmacology research alone has produced more than a thousand peer-reviewed studies since 2017